ATE450255T1 - NSAID FORMULATION CONTAINING A GRANULOSOUS COMPOSITION AND AN EXTRAGRANULOSUS COMPOSITION - Google Patents

NSAID FORMULATION CONTAINING A GRANULOSOUS COMPOSITION AND AN EXTRAGRANULOSUS COMPOSITION

Info

Publication number
ATE450255T1
ATE450255T1 AT02730465T AT02730465T ATE450255T1 AT E450255 T1 ATE450255 T1 AT E450255T1 AT 02730465 T AT02730465 T AT 02730465T AT 02730465 T AT02730465 T AT 02730465T AT E450255 T1 ATE450255 T1 AT E450255T1
Authority
AT
Austria
Prior art keywords
composition
granulosous
extragranulosus
formulation containing
nsaid formulation
Prior art date
Application number
AT02730465T
Other languages
German (de)
Inventor
Tracey RHOADES
Robert Sherry
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of ATE450255T1 publication Critical patent/ATE450255T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02730465T 2001-06-07 2002-05-30 NSAID FORMULATION CONTAINING A GRANULOSOUS COMPOSITION AND AN EXTRAGRANULOSUS COMPOSITION ATE450255T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113839.5A GB0113839D0 (en) 2001-06-07 2001-06-07 Therapeutic agents
PCT/GB2002/002536 WO2002098392A1 (en) 2001-06-07 2002-05-30 Nsaid formulation comprising a granular composition and an extra-granular composition

Publications (1)

Publication Number Publication Date
ATE450255T1 true ATE450255T1 (en) 2009-12-15

Family

ID=9916080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02730465T ATE450255T1 (en) 2001-06-07 2002-05-30 NSAID FORMULATION CONTAINING A GRANULOSOUS COMPOSITION AND AN EXTRAGRANULOSUS COMPOSITION

Country Status (16)

Country Link
US (1) US20050106235A1 (en)
EP (1) EP1392249B1 (en)
JP (1) JP2004532270A (en)
AR (1) AR034436A1 (en)
AT (1) ATE450255T1 (en)
AU (1) AU2002302786B2 (en)
CA (1) CA2449352C (en)
CZ (1) CZ303694B6 (en)
DE (1) DE60234586D1 (en)
ES (1) ES2335976T3 (en)
GB (1) GB0113839D0 (en)
PL (1) PL213979B1 (en)
PT (1) PT1392249E (en)
RU (1) RU2298404C2 (en)
SK (1) SK52004A3 (en)
WO (1) WO2002098392A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
CA2589079A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
CN101330904B (en) * 2005-12-16 2012-04-18 韩美控股株式会社 Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
EP2307022A4 (en) * 2007-10-31 2011-08-24 Equitech Corp Enhanced nsaid formulations
EP2323976A4 (en) * 2008-08-14 2014-07-02 Shasun Chemicals And Drugs Ltd Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
US20110064813A1 (en) * 2009-09-16 2011-03-17 Charles Vaughn Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet
EP2704696A1 (en) 2012-03-26 2014-03-12 Glatt AG Taste-masked ibuprofen granules
WO2014194872A1 (en) * 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
MX2017002700A (en) * 2014-08-28 2017-08-28 Sanofi Aventis Deutschland Pharmaceutical composition for the treatment of acute tooth or jaw pain.
BE1023057B1 (en) * 2016-06-06 2016-11-16 Nordic Specialty Pharma Bvba Ibuprofen tablet

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (en) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen COMBINATION OF DIHYDROPYRIDINE WITH ACE INHIBITORS AND THEIR USE IN MEDICINAL PRODUCTS
DE3669103D1 (en) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm MEDICINAL PRODUCT CONTAINING IBUPROFEN.
SE463541B (en) * 1987-08-31 1990-12-10 Lejus Medical Ab GRANULATED PRODUCT TRANSFER OF A MELT OF ITSELF AND THE PROCEDURE FOR ITS PREPARATION
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
EP0812589B1 (en) * 1993-12-10 2000-08-16 Fujisawa Pharmaceutical Co., Ltd. Combined antipyretic analgesic drug
AT401871B (en) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh METHOD FOR THE PRODUCTION OF S (+) - IBUPROFEN PARTICLES WITH IMPROVED FLOW PROPERTIES AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS
DE4418837A1 (en) * 1994-05-30 1995-12-07 Bayer Ag Thermal granulation process
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
US5997590A (en) * 1996-11-13 1999-12-07 Quantum Energy Technologies Corp. Stabilized water nanocluster-fuel emulsions designed through quantum chemistry
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
HU227045B1 (en) * 1999-12-09 2010-05-28 Reckitt Benckiser Healthcare Compressed tablet composition comprising a nsaid

Also Published As

Publication number Publication date
RU2298404C2 (en) 2007-05-10
GB0113839D0 (en) 2001-08-01
AR034436A1 (en) 2004-02-25
PL366892A1 (en) 2005-02-07
ES2335976T3 (en) 2010-04-07
JP2004532270A (en) 2004-10-21
AU2002302786B2 (en) 2007-01-18
CA2449352A1 (en) 2002-12-12
EP1392249B1 (en) 2009-12-02
PT1392249E (en) 2010-02-04
CZ303694B6 (en) 2013-03-20
DE60234586D1 (en) 2010-01-14
WO2002098392A1 (en) 2002-12-12
US20050106235A1 (en) 2005-05-19
RU2003135631A (en) 2005-01-20
SK52004A3 (en) 2004-07-07
CZ200427A3 (en) 2005-02-16
CA2449352C (en) 2010-11-30
PL213979B1 (en) 2013-05-31
EP1392249A1 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
NO20031407D0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
DE60207627D1 (en) Coating and coating composition
DE60109335D1 (en) Silicone compound and a make-up composition
NO20025450L (en) New pharmaceutical composition
DE60121155D1 (en) SYNERGISTIC ORAL COMPOSITION AGAINST DENTAL AND GINGIVITIS
DE60232981D1 (en) 3-PHENOXY-4-PYRIDAZINOL DERIVATIVE AND HERBICIDES COMPOSITION CONTAINING THEREOF
DK1417175T3 (en) SUBSTITUTED DIHYDRO-3-HALO-1H-PYRAZOL-5-CARBOXYLATES AND PREPARATION AND USE THEREOF
DE60134851D1 (en) HARDENABLE COMPOSITIONS AND COMPATIBILITY AGENTS
DE60212102D1 (en) A NETWORKABLE POLYETHYLENE COMPOSITION
FR2824267B1 (en) COSMETIC COMPOSITION FILMOGENE
DE50112013D1 (en) DEODORANTIA AND ANTIPERSPIRANTIES
NO20033785D0 (en) Pharmaceutical formulation
NO20035627D0 (en) Pharmaceutical formulation
DK1411921T4 (en) Pharmaceutical compositions containing terbinafine and its use
ATE450255T1 (en) NSAID FORMULATION CONTAINING A GRANULOSOUS COMPOSITION AND AN EXTRAGRANULOSUS COMPOSITION
ATE341948T1 (en) COMPOSITION CONTAINING CREATINE AND CREATININE
DE60131422D1 (en) PREPARATION CONTAINING VITAMIN C COMPONENT AND PIGMENT
DE60212612D1 (en) COLORED PEROXYD AND POLYESTER FORMULATIONS
ATE369137T1 (en) LYOPHILIZED FORMULATION CONTAINING OLNZAPINE
DE60225446D1 (en) FLAME-PROTECTED COMPOSITION AND ARTICLES
FR2819176B1 (en) COSMETIC PELABLE COMPOSITION
FR2830751B1 (en) COSMETIC COMPOSITION FILMOGENE
ATE350029T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN
ATE424813T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING EPINASTINE AND PSEUDOEPHEDRINE
ATE279927T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TOBRAMYCIN AND XANTHANG GUM

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties